Immunome shares owned by Prentice Capital Management
Quarter-by-quarter ownership of Immunome (IMNM) shares owned by Prentice Capital Management
from 13F filings
Historical chart of Prentice Capital Management investment in Immunome
Tip: Access up to 7 years of quarterly data
All positions including Immunome held by Prentice Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Immunome by Prentice Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.2M | 112k | 10.70 |
| 2023-09-30 | $936k | 112k | 8.35 |
| 2023-06-30 | $887k | 112k | 7.91 |
| 2023-03-31 | $2.2M | 432k | 4.99 |
| 2022-12-31 | $1.1M | 498k | 2.21 |
| 2022-09-30 | $3.5M | 792k | 4.44 |
| 2022-06-30 | $2.5M | 792k | 3.21 |
| 2022-03-31 | $4.5M | 792k | 5.68 |
| 2021-12-31 | $11M | 807k | 12.96 |
| 2021-09-30 | $13M | 517k | 24.35 |
| 2021-06-30 | $8.9M | 517k | 17.30 |
| 2021-03-31 | $11M | 332k | 33.88 |
| 2020-12-31 | $4.0M | 417k | 9.68 |
More positions owned by Prentice Capital Management
View all positions for Prentice Capital Management